Notification / Circular No.: File No.: I C-21011/41/2026-eoffice/34688 dated March 27, 2026
Applicable Act / Rule: Drugs and Cosmetics Act, 1940
In the existing process, applications for Written Confirmation (WC) for Active Pharmaceutical Ingredients exported to the European Union were processed through CDSCO via the SUGAM portal with multiple levels of review. These applications are required to comply with Article 46(2)(b) of Directive 2001/83/EC for exports to the EU. The procedure involved both zonal/sub-zonal offices and CDSCO Headquarters, leading to longer processing timelines. To streamline and ensure time-bound disposal, the procedure has now been simplified by reducing duplication in the review process.
Disclaimer: The information contained in this Article is intended solely for personal non-commercial use of the user who accepts full responsibility of its use. The information in the article is general in nature and should not be considered to be legal, tax, accounting, consulting or any other professional advice. We make no representation or warranty of any kind, express or implied regarding the accuracy, adequacy, reliability or completeness of any information on our page/article.